^
No biomarker
Testicular Cancer
etoposide IV
Sensitive: A1 - Approval
No biomarker
Testicular Cancer
cisplatin
Sensitive: A1 - Approval
No biomarker
Testicular Cancer
ifosfamide
Sensitive: A1 - Approval
No biomarker
Testicular Seminoma
TI-CE
Sensitive: A2 - Guideline
No biomarker
Testicular Seminoma
EP
Sensitive: A2 - Guideline
No biomarker
Testicular Seminoma
VeIP
Sensitive: A2 - Guideline
No biomarker
Testicular Seminoma
BEP
Sensitive: A2 - Guideline
No biomarker
Testicular Seminoma
carboplatin
Sensitive: A2 - Guideline
No biomarker
Testicular Seminoma
VIP
Sensitive: A2 - Guideline
TMB-H
Testicular Seminoma
TIP
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
paclitaxel + gemcitabine
Sensitive: A2 - Guideline
MSI-H/dMMR
Testicular Cancer
cemiplimab
Sensitive: A2 - Guideline
TMB-H
Testicular Cancer
pembrolizumab
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
etoposide oral
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
GemOx
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
TI-CE
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
carboplatin + etoposide IV
Sensitive: A2 - Guideline
No biomarker
Testicular Cancer
GemPOx
Sensitive: A2 - Guideline